Jazz Pharmaceuticals Plc (JAZZ)
235.67
+2.66
(+1.14%)
USD |
NASDAQ |
Oct 02, 16:00
235.53
-0.14
(-0.06%)
After-Hours: 20:00
Jazz Pharmaceuticals Max Drawdown (5Y) : 47.55% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 47.55% |
| August 31, 2026 | 47.55% |
| July 31, 2026 | 47.55% |
| June 30, 2026 | 47.55% |
| May 31, 2026 | 47.55% |
| April 30, 2026 | 47.55% |
| March 31, 2026 | 47.55% |
| February 28, 2026 | 47.55% |
| January 31, 2026 | 47.55% |
| December 31, 2025 | 47.55% |
| November 30, 2025 | 47.55% |
| October 31, 2025 | 47.55% |
| September 30, 2025 | 47.55% |
| August 31, 2025 | 47.55% |
| July 31, 2025 | 47.55% |
| June 30, 2025 | 47.55% |
| May 31, 2025 | 47.55% |
| April 30, 2025 | 46.18% |
| March 31, 2025 | 48.83% |
| February 28, 2025 | 54.54% |
| January 31, 2025 | 54.54% |
| December 31, 2024 | 54.54% |
| November 30, 2024 | 54.54% |
| October 31, 2024 | 54.54% |
| September 30, 2024 | 54.54% |
| Date | Value |
|---|---|
| August 31, 2024 | 54.54% |
| July 31, 2024 | 54.54% |
| June 30, 2024 | 54.54% |
| May 31, 2024 | 54.54% |
| April 30, 2024 | 54.54% |
| March 31, 2024 | 54.54% |
| February 29, 2024 | 54.54% |
| January 31, 2024 | 54.54% |
| December 31, 2023 | 54.54% |
| November 30, 2023 | 54.54% |
| October 31, 2023 | 54.54% |
| September 30, 2023 | 54.54% |
| August 31, 2023 | 54.54% |
| July 31, 2023 | 54.54% |
| June 30, 2023 | 54.54% |
| May 31, 2023 | 54.54% |
| April 30, 2023 | 54.54% |
| March 31, 2023 | 54.54% |
| February 28, 2023 | 54.54% |
| January 31, 2023 | 54.54% |
| December 31, 2022 | 54.54% |
| November 30, 2022 | 54.54% |
| October 31, 2022 | 54.54% |
| September 30, 2022 | 54.54% |
| August 31, 2022 | 54.54% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Avadel Pharmaceuticals Plc | 90.89% |
| GH Research Plc | 81.15% |
| Cosmo NV | 70.44% |
| Axsome Therapeutics, Inc. | 79.54% |
| Eli Lilly & Co. | 34.47% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 4.748 |
| Beta (5Y) | 0.3663 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 28.37% |
| Historical Sharpe Ratio (5Y) | 0.2966 |
| Historical Sortino (5Y) | 0.5001 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.66% |